| STLN Market Cap History Table | ||||||
Below is a table of the STLN market cap history going back to 4/30/2026:
Also see: STLN Shares Outstanding History and STLN YTD Return |
As of 7/30/2026 Starling Oncology has a market cap of 516.71 million. Investors often follow the STLN market cap history to compare the size of the company over time.
This page shows STLN market capitalization trends over time, with 2 market cap datapoints presented, dating back to 4/30/2026.

| STLN Market Cap History Table | ||||||
Below is a table of the STLN market cap history going back to 4/30/2026:
Also see: STLN Shares Outstanding History and STLN YTD Return |
| STLN Market Cap History Chart | ||||||
STLN Historical Market Cap: +135.92% CAGR
Mouse over chart for data details
| ||||||
| STLN Stock Price Chart |
| About Starling Oncology Inc |
| The Oncology Institute, Inc. is a value-based oncology company. Co. manages community-based oncology practices which serve patients at 83 clinic locations across 15 markets and five states throughout the U.S.. Co.'s segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion and dispensary, radiation, programs like outpatient blood product transfusions, along with 24/7 patient support. Co., through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. We show 2 historical shares outstanding datapoints in our STLN shares outstanding history coverage, used to compute STLN market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing STLN market cap history over the course of time is important for investors interested in comparing STLN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of STLN versus a peer is one thing; comparing STLN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like STLN can fluctuate over the course of history. With this page we aim to empower investors researching STLN by allowing them to research the STLN market cap history. |
| STLN Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: The Importance of Market Cap | |
|
| STLN Share Performance |
| Market Cap Peers |
| Starling Oncology (STLN) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
STML Market Cap History STOK Market Cap History STRO Market Cap History STSA Market Cap History STSS Market Cap History STTK Market Cap History SUPN Market Cap History SURF Market Cap History SVA Market Cap History SVRA Market Cap History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.